Time to Reconsider Routine Timely Anti-epileptic Medication: Raising Hope with a “Smart” Nanoengineered System  

作　　者：Yingying Tang Jianan Quan Weijie Zhou Haoliang Zhou 

机构地区：[1]Department of Pharmacy,Women’s Hospital,School of Medicine,Zhejiang University,Hangzhou,310000,China

出　　处：《Neuroscience Bulletin》2022年第8期973-975,共3页神经科学通报（英文版）

摘　　要：Despite the substantial advances achieved in the development of anti-epileptic treatments,pharmacotherapy is still the optimal choice for patients with epilepsy(PWEs)[1].Once diagnosed,PWEs are required by clinicians to take anti-epileptic drugs(AEDs)orally in a continuous manner(usually twice or thrice daily).The majority of patients need months to years to achieve desirable seizure control and meet the criterion of drug withdrawal[2].However,this routine prophylactic medication in a long-term manner concomitantly imposes a heavy economic burden and unwanted side-effects such as drowsiness and ataxia.

关 键 词：epileptic ROUTINE EPILEPSY 

分 类 号：R741.04[医药卫生—神经病学与精神病学]